First Horizon Advisors’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67 | Hold |
10
| – | – | ﹤0.01% | 2306 |
|
|
2025
Q1 | $65 | Hold |
10
| – | – | ﹤0.01% | 2298 |
|
|
2024
Q4 | $81 | Hold |
10
| – | – | ﹤0.01% | 2257 |
|
|
2024
Q3 | $82 | Hold |
10
| – | – | ﹤0.01% | 2294 |
|
|
2024
Q2 | $70 | Hold |
10
| – | – | ﹤0.01% | 2271 |
|
|
2024
Q1 | $106 | Hold |
10
| – | – | ﹤0.01% | 2273 |
|
|
2023
Q4 | $80 | Hold |
10
| – | – | ﹤0.01% | 2352 |
|
|
2023
Q3 | $82 | Sell |
10
-3,000
| -100% | -$25.9K | ﹤0.01% | 2372 |
|
|
2023
Q2 | $24.1K | Hold |
3,010
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q1 | $24.4K | Hold |
3,010
| – | – | ﹤0.01% | 1188 |
|
|
2022
Q4 | $18.9K | Hold |
3,010
| – | – | ﹤0.01% | 1274 |
|
|
2022
Q3 | $21K | Sell |
3,010
-2,597
| -46% | -$18K | ﹤0.01% | 1214 |
|
|
2022
Q2 | $45K | Buy |
5,607
+2,578
| +85% | +$36K | ﹤0.01% | 967 |
|
|
2022
Q1 | $70K | Sell |
3,029
-2,054
| -40% | -$50.2K | ﹤0.01% | 558 |
|
|
2021
Q4 | $139K | Sell |
5,083
-344
| -6% | -$9.21K | ﹤0.01% | 586 |
|
|
2021
Q3 | $150K | Buy |
5,427
+10
| +0.2% | +$284 | ﹤0.01% | 564 |
|
|
2021
Q2 | $157K | Hold |
5,417
| – | – | 0.01% | 441 |
|
|
2021
Q1 | $171K | Hold |
5,417
| – | – | 0.01% | 408 |
|
|
2020
Q4 | $111K | Buy |
5,417
+451
| +9% | +$8.41K | 0.01% | 412 |
|
|
2020
Q3 | $77K | Buy |
4,966
+347
| +8% | +$5.98K | 0.01% | 449 |
|
|
2020
Q2 | $84K | Buy |
4,619
+616
| +15% | +$10.9K | 0.01% | 419 |
|
|
2020
Q1 | $61K | Buy |
4,003
+181
| +5% | +$4.36K | 0.01% | 447 |
|
|
2019
Q4 | $113K | Buy |
+3,822
| New | +$99.4K | 0.01% | 403 |
|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$48K | – | 1538 |
|
|
2018
Q1 | $48K | Hold |
3,000
| – | – | ﹤0.01% | 501 |
|
|
2017
Q4 | $62K | Hold |
3,000
| – | – | 0.01% | 479 |
|
|
2017
Q3 | $43K | Hold |
3,000
| – | – | ﹤0.01% | 537 |
|
|
2017
Q2 | $52K | Hold |
3,000
| – | – | 0.01% | 478 |
|
|
2017
Q1 | $33K | Hold |
3,000
| – | – | ﹤0.01% | 654 |
|
|
2016
Q4 | $74K | Hold |
3,000
| – | – | 0.01% | 446 |
|
|
2016
Q3 | $74K | Hold |
3,000
| – | – | 0.01% | 441 |
|
|
2016
Q2 | $60K | Buy |
+3,000
| New | +$84.9K | 0.01% | 478 |
|
|
2015
Q4 | – | Sell |
-768
| Closed | -$136K | – | 1264 |
|
|
2015
Q3 | $136K | Sell |
768
-21
| -3% | -$4.9K | 0.02% | 342 |
|
|
2015
Q2 | $175K | Sell |
789
-196
| -20% | -$43.5K | 0.03% | 327 |
|
|
2015
Q1 | $198K | Sell |
985
-207
| -17% | -$36.7K | 0.03% | 313 |
|
|
2014
Q4 | $170K | Sell |
1,192
-1,247
| -51% | -$168K | 0.03% | 338 |
|
|
2014
Q3 | $319K | Buy |
2,439
+148
| +6% | +$17.6K | 0.05% | 243 |
|
|
2014
Q2 | $269K | Buy |
2,291
+997
| +77% | +$127K | 0.04% | 293 |
|
|
2014
Q1 | $167K | Buy |
1,294
+210
| +19% | +$28.7K | 0.02% | 333 |
|
|
2013
Q4 | $145K | Buy |
1,084
+218
| +25% | +$23.9K | 0.02% | 343 |
|
|
2013
Q3 | $90K | Sell |
866
-6
| -0.7% | -$585 | 0.01% | 387 |
|
|
2013
Q2 | $75K | Buy |
+872
| New | +$68.7K | 0.04% | 173 |
|
Other funds holding BHC
IC
GAM
PC
MRCP
First Horizon Advisors's BHC Position: Q2 2025 in Review
First Horizon Advisors held its Bausch Health (BHC) position steady in Q2 2025 at 10 shares worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #2306.
First Horizon Advisors first reported a position in BHC in Q2 2013 and has held it in 41 quarters since. The position peaked at $319K in Q3 2014. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.
- First Horizon Advisors held 10 shares of Bausch Health worth $67 as of Q2 2025.
- First Horizon Advisors left its Bausch Health share count unchanged in Q2 2025.
- Bausch Health made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2306 holding.
- First Horizon Advisors first reported a position in Bausch Health in Q2 2013 and has held it in 41 quarters since.
- First Horizon Advisors's Bausch Health position peaked at $319K in Q3 2014.
- 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.